The UK government is considering an anti-obesity injection for children as young as 12, as obesity rates among the young continue to soar, leading to chronic health issues such as diabetes and high blood pressure.

The drug, Semaglutide, has been approved for use in adults, and proponents argue that it could help reduce the need for invasive weight-loss surgery for children. However, opponents are concerned that over-medication of children could occur, and argue that parents should take responsibility for their children's diets rather than relying on drugs.

The drug has not yet been tested for safe and effective use in young people, and critics argue that a long-term solution to obesity requires educating people on proper nutrition and cooking skills.